image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
72afa18de3fd3ef5c5918be6d1af39d8cdcb4ac09f2b9260438a3122266c0d9c.png | complex | <table><tr><td>miRNA Migr. / Inv. / Met.</td><td>Targets</td><td>Cells / Tissue</td><td>Expression</td><td>Function</td><td>Reference</td></tr><tr><td>miR-17 family (20a, 20b)</td><td>TGFßR2</td><td>A549/CDDP</td><td>down</td><td>TGFßR2 suppressor, reverses CDDP-resistance and suppresses metastases</td><td>[8... |
86819affa162f5883bd2baf27ed966441ecd2aac6efd775eb6c7ed5c01e6688b.png | simple | <table><tr><td></td><td>AC-</td><td>AC+</td></tr><tr><td>2.5 Gy/fraction</td><td>94 (A1)</td><td>83 (A3)</td></tr><tr><td>2.0 Gy/fraction</td><td>142 (A2)</td><td>114 (A4)</td></tr></table> |
069b2ffed479cef0278b60a392eb3238f35b0651e83b6f772225bd5be452de33.png | complex | <table><tr><td rowspan="2">Gene ID</td><td colspan="3">Log<sub>2</sub> (RPKM<sub>OXR</sub>/RPKM<sub>WT</sub>)</td><td rowspan="2">Description</td></tr><tr><td>0 h</td><td>6 h</td><td>24 h</td></tr><tr><td colspan="5">Catalase (CAT)</td></tr><tr><td>Os06t0727200-01</td><td>0.79</td><td>1.36 **</td><td>0.79</td><td>catal... |
33c414e689ec1b56672aecf6d272d53ca0e00f4ec0c1f0cfa129dddd4de9ec69.png | complex | <table><tr><td>50 years +</td><td colspan="2">Female</td><td colspan="2">Male</td><td colspan="2">Total</td></tr><tr><td></td><td>N</td><td>%</td><td>n</td><td>%</td><td>N</td><td>%</td></tr><tr><td>Circulatory system diseases</td><td>29</td><td>27.6</td><td>19</td><td>18.6</td><td>48</td><td>23.2</td></tr><tr><td>Tube... |
8d2f0fba4ded7277dc979d18dd963bdfae5e5a130385538edf293b668d77389b.png | simple | <table><tr><td>Device</td><td>Structure</td><td>Thickness (nm)</td><td><i>a</i> (nm)</td><td><i>n</i></td><td><i>λ</i> (nm)</td><td><i>s</i> (μm)</td><td><i>η</i></td></tr><tr><td>A1</td><td>YIG/Ti/Co</td><td>20/1/25</td><td>200</td><td>2, 4</td><td>100</td><td>30</td><td>95%</td></tr><tr><td>A2</td><td>... |
a7044b7715752653954a10520b1d9dc5677a00fce4369578a9ba5b6e97c28056.png | complex | <table><tr><td>Sample</td><td colspan="2">Superoxide Anion Generation (Inh %)</td><td colspan="2">Elastase Release (Inh %)</td></tr><tr><td>A-EtOH</td><td>90.1 ± 5.3</td><td>**</td><td>85.3 ± 0.8</td><td>**</td></tr><tr><td>A-BuOH</td><td>93.9 ± 8.3</td><td>**</td><td>77.6 ± 2.4</td><td>**</td></tr>... |
b5afabe4f42bbad4cf5ce15df13037eeff8796ddf001de024bb6ee2a05a6d004.png | simple | <table><tr><td></td><td>E50</td><td>E60</td><td>E70</td></tr><tr><td>Total clean reads</td><td>57,050,205</td><td>60,029,490</td><td>61,295,544</td></tr><tr><td>Total clean nucleotides</td><td>11,410,041,000</td><td>12,005,898,000</td><td>12,259,308,800</td></tr><tr><td>Total trinity transcripts</td><td>61,057</td><td>... |
2c2395d9674077ece93f47e1d15bc3bbf433a90396972c7b4c94e4bf60fb06a3.png | simple | <table><tr><td>OD values</td><td>Biofilm formation</td></tr><tr><td>≤ODc</td><td>Non</td></tr><tr><td>2 × ODc ≤ OD > ODc</td><td>Weak</td></tr><tr><td>4 × ODc ≤ OD > 2 × ODc</td><td>Moderate</td></tr><tr><td>>4 × ODc</td><td>High</td></tr></table> |
64e25abec7ade13432c1e06de9221d66dd08c2f4cf3dea67e580cc14efde4a77.png | complex | <table><tr><td>Scale</td><td>Subscale</td><td> M</td><td> SD</td><td>Extreme negative responders (%)<sup>a</sup></td></tr><tr><td rowspan="4">Marcus</td><td>Prognosis for recovery (recovery)</td><td>3.01</td><td>1.37</td><td>—</td></tr><tr><td>Alcoholism and character defect (character defect)</td><td>2.59</td><t... |
25ae47e661d45b275e7437513f9f9c1a91f1c52f5708b7c8b7d05d15e702c4b7.png | complex | <table><tr><td></td><td colspan="4">Patients</td></tr><tr><td></td><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td>Management</td><td></td><td></td><td></td><td></td></tr><tr><td>Operation</td><td>No</td><td>Resection and IVC PTFE Patch</td><td>Resection and primary repair</td><td>Resection and IVC Vein Patch</td>... |
fc3f005704356b5711a1909e38424d8059caa9b22d067007f1a692ddea8edba1.png | complex | <table><tr><td rowspan="3">Baseline/outcome measure</td><td rowspan="3">Questionnaire</td><td colspan="4">Survey administration times</td></tr><tr><td>Baseline</td><td colspan="2">Time 1</td><td>Time 2</td></tr><tr><td>(after referral for abnormal screen)</td><td>(within 3 months of<i>negative</i>diagnosis)</td><td>(wi... |
dd14cd298baa5a48fe22ee76f53f48ddf9960a4401940560fcbf76dcdcf4f8f7.png | complex | <table><tr><td></td><td colspan="4">Clusters</td></tr><tr><td></td><td>The comprehensive</td><td>The theoretician</td><td>The minimalist</td><td>The structural</td></tr><tr><td>South American sample areas</td><td>14,1</td><td>7</td><td>31</td><td>47.9</td></tr><tr><td>European sample areas</td><td>24</td><td>49.5</td><... |
e23320a09c944bd0157e5bfc81e60300e590b3a2e8bd24a44d1598721686430b.png | simple | <table><tr><td>Resection margin</td><td>Recurrence rate No. patients (%)</td><td>Surgery and radiotherapy No. (%)</td><td>Surgery alone No. (%)</td></tr><tr><td>R0</td><td>5/16 (31)</td><td>2/4 (50)</td><td>3/12 (25)</td></tr><tr><td>R1</td><td>30/47 (64)</td><td>27/36 (75)</td><td>3/11 (27)</td></tr><tr><td>R2</td><td... |
75e467cba65d6580a1e75e87e6ee763948ebc348c58f40957c4ce29359a7ccb1.png | simple | <table><tr><td> </td><td>Phase</td><td>Morphology</td><td>Secondary phase</td></tr><tr><td>1,098 K/8 h</td><td> </td><td> </td><td> </td></tr><tr><td> Undoped</td><td>Rutile</td><td>Nanorod</td><td>-</td></tr><tr><td> 0.5% Co</td><td>Rutile</td><td>Nanorod</td><td>-</td></tr><tr><td> 1% Co</td><td>Rutile</td><td>Nanoro... |
ffc86d2823847f057b5e4f94142ca6976449e8f366a40edbcec5bb02f5fc13f5.png | simple | <table><tr><td></td><td>Men (<i>n</i> = 123)</td><td>Women (<i>n</i> = 169)</td><td>Total (<i>n</i> = 292)</td></tr><tr><td>Non-smokers, <i>n</i> (%)</td><td>47 (38.2)</td><td>74 (43.8)</td><td>121 (41.4)</td></tr><tr><td>Ever-smokers, <i>n</i> (%)</td><td>76 (61.8)</td><td>95 (56.2)</td><td>171 (58.6)</td></tr><tr><td... |
6f383440da897e7c34cd1524500ff2b8c5830511982d07f4397eec98075cb1c6.png | simple | <table><tr><td>Question number</td><td>Question</td></tr><tr><td>1.</td><td>Please tell me all about your rotator cuff tear/shoulder? (follow up questions to find out when and and how the tear happened and obtain narrative history from participant).</td></tr><tr><td>2.</td><td>Please tell me about how your shoulder tea... |
20d0ef8b8fb19928f950c22ae20f7aeb93bd7f4b5c4cb36025ae204a36f66c01.png | simple | <table><tr><td>Event</td><td>Grade 1 (0)</td><td>Grade 2 (1–2)</td><td>Grade 3 (3–6)</td><td>Grade 4 (> 6)</td><td>Na</td></tr><tr><td>Head lifting (n)</td><td>153 (88.4%)</td><td>5 (2.9%)</td><td>4 (2.3%)</td><td>6 (3.5%)</td><td>5 (2.9%)</td></tr><tr><td>Paddling (one limb) (n)</td><td>159 (91.9%)</td>... |
e06f0286dfc72e1572a10b1bde12497d365ca297d9ab5dc766f0d5af9d9e40d2.png | simple | <table><tr><td>Generic name</td><td>Trade name</td><td>Number of cases of monotherapy</td></tr><tr><td>Losartan</td><td>Nu-lotan®</td><td>214</td></tr><tr><td>Valsartan</td><td>Diovan®</td><td>266</td></tr><tr><td>Telmisartan</td><td>Micardis®</td><td>185</td></tr><tr><td>Candesartan</td><td>Blopress... |
e2e32c476d940941003dc1b874aac51ba628fa877458796425abdb2c8961895a.png | simple | <table><tr><td>Parameter</td><td>Level 1</td><td>Level 2</td><td>Level 3</td><td>Level 4</td><td>Level 5</td></tr><tr><td>100-OD (% sat.)</td><td>≤10</td><td>≤20</td><td>≤30</td><td>≤50</td><td>>50</td></tr><tr><td>BOD<sub>5</sub> (O<sub>2</sub> mg/L)</td><td><2.5</td><td>≤4</td><td>... |
6a0794db078e4abb0e1f784a6a84828b3c5f0c663a4a459535891903ee78d177.png | complex | <table><tr><td>Re-revision diagnosis</td><td colspan="2">UKA to UKA minor</td><td colspan="2">UKA to UKA major</td><td colspan="2">UKA to TKA</td><td colspan="2">TKA to TKA</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Loosening/lysis</td><td>17</td><... |
10731fdc0c192a221a4a2cddfd60e3a57f1d5df481b23fc1b7d8781f3f5b8a8b.png | complex | <table><tr><td>Diagnosis in MRI</td><td>Specific abnormalities in MRI</td><td><i>N</i></td><td>Total number (%)</td></tr><tr><td>Abnormal MRI</td><td> </td><td> </td><td>13 (52%)</td></tr><tr><td rowspan="2">Hepatic dysmorphia</td><td>Included lobulation of liver surface</td><td>3</td><td rowspan="2">3 (12%)</td></tr><... |
d6262c934d811551f3a5e04ce8d29c5e590e7b6b90f56b1b703c225426f06e50.png | simple | <table><tr><td>Variable</td><td>OR [95%CI]</td><td>P value</td></tr><tr><td>Steroids before ICU stay</td><td>0.77 [0.17-3.49]</td><td>0.74</td></tr><tr><td>Steroids during ICU stay</td><td> </td><td> </td></tr><tr><td>No Steroid</td><td>5.64 [0.70-45.5]</td><td> </td></tr><tr><td>Low Dose Steroid</td><td>1</td><td>0.02... |
0f9d96f0b72e8d74928ed223907880e61d0b0d4b295cd37a42eb78de678c8b3d.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td>C</td><td>NC</td><td><i>p</i>-value</td><td>C</td><td>NC</td><td><i>p</i>-value</td></tr><tr><td>Dietary component</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Energy (kJ)</td><td>9665</td><td>986... |
c2c7c821612ce295ebf8553c1f2f9f04fbd1eedbb8499e03049ce0030013e504.png | simple | <table><tr><td>Variablea</td><td>HR (95% CI)</td><td><i>P</i></td></tr><tr><td>Bowel obstruction/perforation (positive vs negative)</td><td>4.118 (2.270-7.471)</td><td><.001</td></tr><tr><td>Lymphovascular invasion (positive vs negative)</td><td>1.766 (1.156-2.697)</td><td>.009</td></tr><tr><td>Five-gene molecular s... |
9e98077623fc16c7449c488bcf030ef762905d066651c779620c12c47f89bd47.png | simple | <table><tr><td>Subject</td><td>R (mean ± std. deviation)</td></tr><tr><td>1</td><td>0.8084 ± 0.0140</td></tr><tr><td>2</td><td>0.7605 ± 0.1104</td></tr><tr><td>3</td><td>0.7915 ± 0.0147</td></tr><tr><td>4</td><td>0.8045 ± 0.0173</td></tr><tr><td>5</td><td>0.7970 ± 0.0204</td></tr></table> |
318ab7b48e1d03e83ed69b86c9d5420be14cfb5142ac491330000d1f6019738c.png | complex | <table><tr><td>% Coronary Vasoreactive Change with IHE vs. Coronary Wall Measure:</td><td>% area change</td><td>% velocity change</td><td>% flow change</td></tr><tr><td rowspan="2">Healthy: Mean Coronary Wall Thickness</td><td><i>R</i> = -0.17</td><td><i>R</i> = 0.02</td><td><i>R</i> = -0.02</td></tr><tr><td><i>P</i> =... |
6a2464423d34de68930744a48e292631e1dd45543601c31834fa860cf5856b02.png | complex | <table><tr><td rowspan="3">Survey Data</td><td colspan="2">Model 1–30 min/day</td><td colspan="2">Model 2–60 min/day</td><td colspan="4">Model 3 – KKD</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="2"><i>Active</i> vs <i>Inactive</i></td><td colspan="2"><i>Moderately Active</i> vs <i>In... |
a56b85e332f7f96fcd9850a8fe0dfb90a9f8748e61a88def87f5f22752e85c14.png | simple | <table><tr><td> </td><td>GOLD II</td><td>GOLD III</td><td>GOLD IV</td><td>Total</td></tr><tr><td> </td><td>(n = 12)</td><td>(n = 21)</td><td>(n = 10)</td><td>(n = 43)</td></tr><tr><td>Short acting bronchodilator</td><td>75.0%</td><td>80.9%</td><td>80.0%</td><td>79.1%</td></tr><tr><td>Combined LABA with steroid</td><td>... |
dc2990f6786ed9b47af01a5071897fbd3e55a5db4554e90b007e2408500608f4.png | complex | <table><tr><td>Adipokine</td><td colspan="2">Study time point</td><td>Media alone</td><td>Stimulated</td><td><i>P</i> values</td></tr><tr><td rowspan="4">Adipsin</td><td rowspan="2">Pre-int</td><td>Mean (SEM)</td><td>3.83 (2.12)</td><td>4.74 (3.89)</td><td>0.743 (ns)</td></tr><tr><td>Range</td><td>0–23.14</td><td... |
441eb1c54a2f03d7a83523765491f3808cb5d892dbaceed1350067e33fb87282.png | complex | <table><tr><td>Grade</td><td colspan="3">Normal group</td><td colspan="8">Osteoarthritis group</td></tr><tr><td></td><td>12 F</td><td>39 F</td><td>43 M</td><td>42 M</td><td>49 F</td><td>54 F</td><td>55 M</td><td>58 F</td><td>65 F</td><td>66 F</td><td>70 F</td></tr><tr><td>Transverse section</td><td>0</td><td>0</td><td>... |
fe4947d31561efd4455d129c81aa3fa9eae1087c0acf9a6ad6019c903c49a11f.png | simple | <table><tr><td>Variable</td><td>Comparison used in rate ratio</td><td>Rate ratio (other death/HIV/TB death)</td><td>95% Confidence interval (<i>p</i> value)</td></tr><tr><td>Sex</td><td>Male/female</td><td>1.12</td><td>0.99–1.27 (0.077)</td></tr><tr><td>Country of origin</td><td>South Africa/Mozambique</td><td>0.... |
afb3f9e5bd4f871f1d3b263a3e2e79aa62313b08f41ba94b092294f589822ae3.png | complex | <table><tr><td colspan="2">ABRA system delayed closure system</td></tr><tr><td>Pros</td><td>Cons</td></tr><tr><td>ABRA abdominal wall closure can restore lost abdominal domain and achieve complete repair of the musculofascial support of the abdominal wall, achieving primary closure. The sutures can be tightened at sequ... |
f4064b9fdbc7cce1191133eebba77c9db43fd93e5ef4f88585979e6da361816d.png | simple | <table><tr><td>Origin</td><td>Prenatal</td><td>Delivery room</td></tr><tr><td>Greek</td><td>34/2467 (1.4%)</td><td>3/174 (1.7%)</td></tr><tr><td>Albanian</td><td>20/227 (8.8%)</td><td>6/61 (9.8%)</td></tr><tr><td>Others*</td><td>11/135 (8.1%)</td><td>2/27 (7.4%)</td></tr><tr><td>Total</td><td>65/2829 (2.3%)**</td><td>1... |
b0817948de46d0b3c6551eaebc4dd0fa5b3fb6c4b03315a7a191845effd24884.png | simple | <table><tr><td>Study characteristics</td><td>Nepal trial*</td><td>Bangladesh trial</td><td>Pakistan trial</td></tr><tr><td>Type of study</td><td>Cluster RCT</td><td>Cluster RCT</td><td>2 × 2 factorial design cluster RCT</td></tr><tr><td>No. clusters (average size)</td><td>413 (700)</td><td>133 (4100)</td><td>187 (... |
145b658c4b48cbc5eb6ee5a81f6b081a4f8504427ce2ea7d2e7479b3869c280a.png | complex | <table><tr><td></td><td colspan="2">WHO guideline<sup>a</sup></td><td colspan="2">Swiss TPH guideline<sup>a</sup></td></tr><tr><td></td><td><i>Trichuris trichiura</i></td><td><i>Ascaris lumbricoides</i></td><td><i>Trichuris trichiura</i></td><td><i>Ascaris lumbricoides</i></td></tr><tr><td>Total number of Kato-Katz thi... |
6abf16cd0b41fb3a390497ed183cfe53079fb71f04fb53f6ea5fc44157f086bf.png | complex | <table><tr><td rowspan="2">Biologics</td><td colspan="3">Pooled incremental efficacy</td><td colspan="3">6-month incremental cost-effectiveness ratio</td></tr><tr><td>Base case</td><td>Best case </td><td>Worst case</td><td>Base case</td><td>Best case</td><td>Worst case </td></tr><tr><td>Etanercept</td><td>58%</td><td>7... |
5f6efd8a98a9d3a8efa8db04b6c10aa609213228e12e9d16fcfef1390f330e92.png | complex | <table><tr><td colspan="2">Architecture</td><td>DeepLab without CRF (Chen et al., 2014)</td><td>FCN (Long et al., 2015)</td><td>U-Net (Ronneberger et al., 2015)</td><td>DeconvNet (Noh et al., 2015)</td></tr><tr><td colspan="2">Side length of receptive field</td><td>44</td><td>52</td><td>46</td><td>44</td></tr><tr><td r... |
881dc21d1cb9252d760f00d67998f553edca3f1665832524d94c9b27eae25418.png | complex | <table><tr><td></td><td colspan="3">All suicide</td><td colspan="3">Firearm suicide</td><td colspan="3">Nonfirearm suicide</td></tr><tr><td></td><td>IRR*</td><td>95% CI</td><td>P-value</td><td>IRR*</td><td>95% CI</td><td>P-value</td><td>IRR*</td><td>95% CI</td><td>P-value</td></tr><tr><td>Crude analyses</td><td></td><t... |
9322965dadc8a9a52fd5a7c5faa7d0b4d3d3d49ae7ea439b99080bf82ff05e04.png | simple | <table><tr><td> </td><td>Low-income countries</td><td>Middle-income countries</td><td>High-income countries</td></tr><tr><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Number of global countries where data is < 5% gross monthly income</td><td>5</td><td>78</td><td>46</td></tr><tr><td>% of subscriptions with bro... |
e9d01862d3bdafff21ee423db8d43c950c69c544c86b6a98fcb0d2e3c2390fbe.png | simple | <table><tr><td>Variable</td><td>RBHS group (<i>n</i> = 36)</td><td>Control group (<i>n</i> = 38)</td><td><i>P</i>value</td></tr><tr><td>Composite outcome (any morbid event)</td><td>1 (2.8)</td><td>5 (13.1)</td><td>0.20</td></tr><tr><td>Morbid events<sup>a</sup></td><td> </td><td> </td><td> </td></tr><tr><td>Infection</... |
654c68c317a8e166c351f5696c53739ea0216d723d9733c8cae47a5f3b2227db.png | simple | <table><tr><td>Country</td><td>Acronym of the Study</td><td>Year of Recruitment</td><td>Age Class</td><td><i>n</i></td><td>GM</td><td>50p</td><td>95p</td><td>Reference</td></tr><tr><td>Italy</td><td>SEpiAs</td><td>2010</td><td>20–44</td><td>271</td><td>8.76</td><td>7.78</td><td>86.28</td><td>[49]</td></tr><tr><td... |
ea1e6b33085e4c667c7e53f6fae6b8121c82a1ea38d0e19a1fd7dbd2191a9f28.png | simple | <table><tr><td>Data Set</td><td>Original</td><td>Global Median</td><td>Quantile</td><td>Cyclic Loess</td><td>IS.Median</td><td>Invariant Set</td></tr><tr><td>PSD</td><td>4.18% (1.96%)</td><td>2.15% (1.41%)</td><td>1.97% (1.12%)</td><td>2.12% (1.39%)</td><td>3.09% (1.51%)</td><td>1.99% (1.29%)</td></tr><tr><td>CSP</td><... |
4a742c470c67b5180dab320c5f43da5d4283917c4d0c3004c8edabb5a921548a.png | simple | <table><tr><td>Clinical indicators</td><td>OR (95 % CI)</td><td><i>p</i>-value</td><td>Multivariable OR (95 % CI)</td><td><i>p</i>-value</td></tr><tr><td>LDL-C goal attainment</td><td></td><td></td><td></td><td></td></tr><tr><td> LDL-C ≥ 100 mg/dL</td><td>1.00</td><td></td><td>1.00</td><td></td></tr><tr><td> LDL-... |
3ffddc2eb3a94c219a38abf48d0b3018ee3c1a9728bf0c0fd4666188a0d930b9.png | complex | <table><tr><td>Function</td><td>Gene</td><td>Accession no.<sup>∗</sup></td><td colspan="2">Chromosome</td></tr><tr><td></td><td></td><td></td><td><i>T. aestivum</i></td><td><i>Ae. umbellulata</i></td></tr><tr><td>Protein biosynthesis</td><td></td><td></td><td></td><td></td></tr><tr><td>HMW glutenins</td><td>Glu-1... |
dee34620c4a39b8a1a618328528c813e5b3176e81f5d82a936727bf51a862d6f.png | simple | <table><tr><td></td><td>RDP (<i>n</i> = 7)</td><td>LDP (<i>n</i> = 21)</td><td><i>P</i> value</td></tr><tr><td>Mean operative time (min)</td><td>368</td><td>210</td><td>0.0002</td></tr><tr><td>Mean blood loss (mL)</td><td>200</td><td>250</td><td>0.451</td></tr><tr><td>Transfusion (no. of patients) (%)</td><td>0</td><td... |
c56c1c831ace51c4e392411aa13a46bbefd3a729537a1fea3bfd01d72a73ea33.png | simple | <table><tr><td>Group</td><td>Drug</td><td>Frequency</td><td>Percent (n/N) <sup>b</sup></td></tr><tr><td>β-lactam</td><td></td><td>26</td><td>28.9 (26/90)</td></tr><tr><td> Penicillin</td><td>PenicillinG</td><td>11</td><td>29.0 (11/27)</td></tr><tr><td></td><td>Ampicillin</td><td>12</td><td>32.4 (12/26)</td></tr><t... |
b08069a254d02a29e242b1f148977fa3100aa37d0d898366a08ff3764f2f2f84.png | complex | <table><tr><td rowspan="2">Group</td><td rowspan="2">Dose (mg/kg)</td><td colspan="4">Mean Fasting Blood Sugar Level (mM)</td></tr><tr><td>0 min</td><td>30 min</td><td>60 min</td><td>120 min</td></tr><tr><td>NC</td><td>–</td><td>4.32 ± 0.88</td><td>13.65 ± 1.24</td><td>8.94 ± 1.47</td><td>4.89 ... |
49ce65355e37577062f7b2ecc5572e2c83cf4597cc0ec5ce5e0d72cd8c9fe952.png | complex | <table><tr><td>Animal ID</td><td>Sex</td><td><i>M</i><sub>b</sub> (kg)</td><td>SL (cm)</td><td>G (cm)</td><td>[Hct]</td><td colspan="2">N</td><td colspan="2"><i>f</i><sub>R</sub> (breaths ⋅ min<sup>-1</sup>)</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>Air</td><td>Water</td><td>Air</td><... |
5b4729d229730eb04707971603b8a7559b32434812f4ee49e113a02e4a377b53.png | complex | <table><tr><td rowspan="2">Predictor</td><td colspan="4">1 year</td><td colspan="4">2 years</td></tr><tr><td>Unadjusted OR (95% CI)</td><td>p Value</td><td>Adjusted OR (95% CI)</td><td>p Value</td><td>Unadjusted OR (95% CI)</td><td>p Value</td><td>Adjusted OR (95% CI)</td><td>p Value</td></tr><tr><td>HAQ score</td><td>... |
e20a62f2968f5a3b6096a5f6ce779091a58acd098fb53b99abffe5ef4eda4403.png | simple | <table><tr><td>Type</td><td>CVID (<i>n</i> = 34)</td><td>IgGSD (<i>n</i> = 398)</td><td>Value of <i>P</i></td></tr><tr><td>B∗07</td><td>29.4 (10)</td><td>22.9 (91)</td><td>0.3866</td></tr><tr><td>B∗08</td><td>38.2 (13)</td><td>25.4 (101)</td><td>0.1025</td></tr><tr><td>B∗13</td><td>0</td><td>4.3 (17)<... |
5876a56e841c3bf7f53a016c7bbe4635a7f206815d4b365a27cf67c8a6f57f1b.png | simple | <table><tr><td>Study Cohort</td><td>Number</td><td>Percentages</td></tr><tr><td>Women</td><td>36</td><td>34</td></tr><tr><td>Men</td><td>71</td><td>66</td></tr><tr><td>Mean Age 64.7 years</td><td></td><td></td></tr><tr><td>(Range 31–95 years)</td><td></td><td></td></tr><tr><td>Clinical Neuropathic Syndrome</td><t... |
2451c38c13d8d4146e1b0623a4cf77f006a9be0cc7e0ec98aa00f22dd7361c9b.png | simple | <table><tr><td>Type</td><td>Strain/<i> Transgene</i><sup>b</sup></td><td>Main pattern<sup>c</sup></td><td>Myoepithelial differentiation<sup>d</sup></td><td>EMT (%)<sup>e</sup></td><td>K1</td><td>K5</td><td>K6</td><td>K8/18</td><td>K10</td><td>K14</td><td>K17</td><td>FLG</td><td>IVL</td><td>LOR</td><td>THH</td><td>SMA</... |
2ac2c322881f3d9db94e42ef4a4511c8b4121130b88ee846d58ef20c560a15f7.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">HAA intake</td><td></td></tr><tr><td>Low</td><td>Moderate</td><td>High</td><td><i>P</i><sub>interaction</sub></td></tr><tr><td colspan="5"><i>NAT2</i>-imputed phenotype</td></tr><tr><td> Rapid or intermediate acetylator</td><td></td><td></td><td></td><td></td></tr><tr><td... |
77ec8ea3f346616ea45d6fc366882b243a2aa12d55e7120ad7f96cc6626718f2.png | complex | <table><tr><td>EORTC QLQ-C30 subscales</td><td>Item</td><td colspan="4">Baseline</td><td colspan="4">2 weeks post-RT</td></tr><tr><td> </td><td> </td><td>IG (n = 89)</td><td>CON (n = 89)</td><td> </td><td> </td><td>IG (n = 89)</td><td>CON (n = 89)</td><td> </td><td> </td></tr><tr><td> </td><td> </td><td>Mean(SD)</td><t... |
a4da6baf2a9f4a9ac6462c6e73f82d537be3fee669b49c8626929f23b1502b5b.png | simple | <table><tr><td></td><td>HUS-STEMI I</td><td>HUS-STEMI II</td><td></td></tr><tr><td></td><td>n = 194</td><td>n = 306</td><td></td></tr><tr><td></td><td>%</td><td>%</td><td>p</td></tr><tr><td>Mean age, mean (SD) years</td><td>64.8 (12.9)</td><td>64.3 (14.0)</td><td>0.920</td></tr><tr><td>Age > 75 years</td><td>23.7</t... |
e789d6cfa0348cfe1fe0186a8e1a8ef888b34d4c11ed4ee024474fc3d6a5929c.png | simple | <table><tr><td>Category</td><td>All Respondents (n = 769)</td><td>Nurses (n = 527)</td><td>Physicians (n = 238)</td></tr><tr><td>1 Lack of time<sup>a</sup></td><td>33.0% (254)</td><td>27.3% (144)</td><td>46.2% (110)</td></tr><tr><td>2 Behaviours attributed to women living with abuse</td><td>21.5% (165)</td><td>19.9% (1... |
20156a01ac3d3b8991a93774f5666df81ea8ddb231b41645d932e8a108c289d5.png | simple | <table><tr><td><i>CHEK2 </i>mutation type</td><td>Controls(<i>n </i>= 1,026)<sup>a</sup></td><td>Allelic frequency in controls</td><td>Cases(<i>n </i>= 1,014)<sup>a</sup></td><td>Allelic frequency in cases</td><td>P value</td><td>OR</td><td>95% CI</td></tr><tr><td>Any <i>CHEK2 </i>mutation</td><td>4</td><td>0.39%</td><... |
34f5bf2176f57cb9e66cb401cb5fdf678bd09c332d50efd8955dc46b41a953a9.png | simple | <table><tr><td>Chr</td><td>SNP</td><td>Position</td><td>Minor allele/major allele</td><td>Association <i>p</i>-value</td><td>Allelic OR (95% CI)</td><td>Bonferroni adjusted <i>p</i>-value</td><td>BH-false discovery rate <i>p</i>-value</td><td>Interaction (ADD × sex) <i>p</i>-value</td></tr><tr><td>1</td><td>rs8656... |
e6386c1644aa3c1fdb0e75624296aa796c5eddeb85fe3f548a6803754bb699a5.png | simple | <table><tr><td> </td><td>T1</td><td>T2</td><td>T3</td><td><i>P</i> for trend</td></tr><tr><td>Men (<i>n</i>)</td><td>679</td><td>659</td><td>542</td><td> </td></tr><tr><td> Age (yr)</td><td>58.1 ± 10.6</td><td>54.5 ± 10.3</td><td>51.9 ± 9.4</td><td><0.001</td></tr><tr><td> Weight (kg)</td><td>68.9 ... |
66f2453f01b391cc55c43f3439d8b4518f3b67d9c547360bd1f63d97d91ad752.png | complex | <table><tr><td>Polysaccharide(s)</td><td>Source(s)</td><td>Animals</td><td>Dose/day</td><td>Duration</td><td>CNS tests performed</td><td>Significant effects</td><td>Reference</td></tr><tr><td rowspan="2">Alpha-glucan (isolichenan)</td><td rowspan="2"><i>Cetrariella islandica</i></td><td>5-week-old ♂ Std-ddY mice ... |
d592b6d2899c34ad1c98833a0c1da8b57f8fbdc25558bfe903b7f09eeab19a79.png | complex | <table><tr><td></td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td><td><i>P</i><sub>trend</sub></td></tr><tr><td colspan="6">TyG</td></tr><tr><td> Range</td><td><8.16</td><td>8.16 to 8.47</td><td>8.48 to 8.81</td><td>≥8.82</td><td></td></tr><tr><td> No. of cases</td><td>18</td><td>... |
1c161a4d6cb685a7a1bfd07901c96fd8b16410608cca946c49b17c11ad065c39.png | simple | <table><tr><td>Characteristic</td><td>HES APC<sup>a</sup></td><td>England<sup>b</sup></td></tr><tr><td>Finished consultant episodes</td><td>18731964</td><td></td></tr><tr><td>Admissions</td><td>15892434</td><td></td></tr><tr><td>Admission type</td><td></td><td></td></tr><tr><td> Emergency</td><td>5615707 (30.0)</td><td... |
18a0c09bda3cc11f6eaacc096471a8ed105b481aef3d5fcb7986b2327da527a9.png | complex | <table><tr><td>miRNAs</td><td>Expression in lung cancer</td><td>Cellular processes affected and targets</td><td>Reference</td></tr><tr><td rowspan="3">Let-7 family</td><td rowspan="3">Decreased</td><td>(i) Cell proliferation (KRAS, MYC, and HMGA2)</td><td>[28–30]</td></tr><tr><td>(ii) miRNA maturation Dicer media... |
f6b497bcdffbd4a90b146b1b041d931afb38b61e7470ad6e282c9513b11d257b.png | complex | <table><tr><td> </td><td colspan="3">SL2 clinical data</td><td>SL1 clinical data</td><td>p-value</td></tr><tr><td> </td><td>Pre 24 hour</td><td>Pilot trial (+)</td><td>Post 24 hour</td><td>Pilot trial (+)</td><td>SL1 vs. SL2</td></tr><tr><td>Number of patients:</td><td>9</td><td>9</td><td>9</td><td>9</td><td>/</td></tr... |
766345879b0508585a93b51460f720a59c9ac18718f23bd5ae379f69c7c5763a.png | simple | <table><tr><td>Fatty acid</td><td>Name</td><td>Percentage in EVOO</td><td>mg FAME/g sample</td></tr><tr><td>C16:0</td><td>Palmitic acid</td><td>11,27</td><td>125,41</td></tr><tr><td>C16:1n7</td><td>Palmitoleic acid</td><td>0,86</td><td>9,56</td></tr><tr><td>C17:0</td><td>Margaric acid</td><td>0,04</td><td>0,46</td></tr... |
f5c89fa9ee87ed6e1c5341c6fb8431c1e9b10966a58e580825ab6ef69bafa2a2.png | simple | <table><tr><td>Covariate</td><td>χ<sup>2</sup></td><td>P-value</td><td>Hazard ratio</td><td>95% CI</td></tr><tr><td>Adjacent involvement (with vs. without)</td><td>11.841</td><td>0.001</td><td>2.295</td><td>1.430-3.683</td></tr><tr><td>Mitotic rate (> = 5/50 HPF vs. <5/50 HPF)</td><td>8.895</td><td>0.003</td... |
43b89362bb43a1212c966fb255d8031ebe52ba5096ff6e5e18110555db468bd7.png | complex | <table><tr><td rowspan="2">Assessment</td><td rowspan="2">Group</td><td colspan="2">Mean value (95% confidence interval)</td><td>Paired t test</td><td>1-way ANCOVA</td></tr><tr><td>PRE</td><td>POST</td><td>P (Cohen’s d)</td><td>P (Partial η2)</td></tr><tr><td rowspan="2">FMA<sub>full score</sub></td><td>Clin... |
02a0d2e18f63a62a68e36747766f8a3a3a588b23e55a3df37170224a176f3cf7.png | complex | <table><tr><td> </td><td colspan="2">Validation against our test</td><td colspan="2">Validation against the test in literature</td></tr><tr><td> </td><td>The current experiment (n = 8)</td><td>Predicted value</td><td>Hashemi et al.’s experiment (n > 4)</td><td>Predicted value</td></tr><tr><td>High density</td>... |
82e0a1442e400a6f6a93cb3aea64a984eb88dbe1e6ee51d0201c8383317325bf.png | simple | <table><tr><td></td><td>n</td><td>%</td></tr><tr><td><i>Gender</i></td><td></td><td></td></tr><tr><td> Male</td><td>432</td><td>49.3</td></tr><tr><td> Female</td><td>444</td><td>50.7</td></tr><tr><td><i>Ethnicity</i></td><td></td><td></td></tr><tr><td> White</td><td>536</td><td>61.2</td></tr><tr><td> Non-white</td><td>... |
03305186bf6e520f92ba4af80eef1384d53b5a71565844067af6a2b2426fb2b1.png | simple | <table><tr><td>Variable</td><td>ROSC</td><td>No ROSC</td><td>P value</td></tr><tr><td>Paramedics with prior OHCA case volume ≥ 15 (%)</td><td>24.5</td><td>22.7</td><td><0.01</td></tr><tr><td>Male gender (%)</td><td>60.1</td><td>63.2</td><td>0.01</td></tr><tr><td>Non-Caucasian (%)</td><td>31.7</td><td>29.8</td>... |
f3d6dc897b4090bacc78575c48fa0296ea4edf84de7e36e54a454d0d77ae4642.png | simple | <table><tr><td>Component</td><td>Score</td><td>Definition</td></tr><tr><td>Physical Activity</td><td></td><td></td></tr><tr><td></td><td>0</td><td>No exercise</td></tr><tr><td></td><td>1</td><td>1–149 min of moderate exercise or 1–74 min of vigorous exercise/week</td></tr><tr><td></td><td>2</td><td>150+ min... |
1d4b19eebc8b6a5e56722c8fff8ac365c32c9b934524ea0fb40dbd26ad53378d.png | simple | <table><tr><td>Cancer type</td><td>Reference</td></tr><tr><td>Breast</td><td>Fernandez et al. (19), Gazit et al. (20)</td></tr><tr><td>Prostate</td><td>Daneshmand et al. (23), Fu et al. (24)</td></tr><tr><td>Gastric</td><td>Song et al. (26)</td></tr><tr><td>Ovarian</td><td>Huang, LW et al. (25)</td></tr><tr><td>Endomet... |
1cc55ecb5c31afc3cf1faddd8d26d60293fa8f811141b488f1bfa172b4fe1c0f.png | complex | <table><tr><td>LN</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td> </td><td colspan="2">CD63</td><td> </td></tr><tr><td> </td><td> </td><td>Number of patients, <i>n </i>(%)</td><td>Positive, <i>n</i></td><td>Negative, <i>n</i></td><td>P-value</td></tr><tr><td>MDR1</td><td>Positive... |
4a51aa875303d7dd772fae2f8c792a01127204a2d1efa0fcb9880015b1b0ef70.png | complex | <table><tr><td rowspan="2">Capsules</td><td colspan="3">Spectrophotometric method</td><td colspan="3">Fluorimetric method</td></tr><tr><td>Recovery (%) ± SD<sup>(a)</sup></td><td><i>F </i> value<sup>(b)</sup></td><td><i>t </i> value<sup>(b)</sup></td><td>Recovery (%) ± SD<sup>(a)</sup></td><td><i>F </i> value... |
f93f11c178fd2f256b7976590aa708fe0443803e1b48fb408f1851c4fc0c4681.png | simple | <table><tr><td></td><td>Age (Years)</td><td>Height (cm)</td><td>Weight (kg)</td></tr><tr><td>CFS</td><td>43 ± 4.6</td><td>164 ± 7.3</td><td>73 ± 21.2</td></tr><tr><td>Control</td><td>43 ± 6.5</td><td>167 ± 7.0</td><td>70 ± 16.7</td></tr></table> |
c196951cfb266d3655e64d237ae509e40f09f13b9d0c046379bc0e56be472526.png | complex | <table><tr><td></td><td>General health</td><td>Conditions and symptoms</td><td>Infections</td></tr><tr><td colspan="4">‘Type 1’</td></tr><tr><td> 1a: Emerging female excess</td><td>General health – Past year General health – Past month</td><td>High temperature Rash</td><td>Eye infection Ear infe... |
77d3c275275aaebf41c31adfe7c1328f167546d357ec89bf01a45ff6c833d196.png | simple | <table><tr><td>Sample</td><td>ZKR <sup>a</sup>_S1 <sup>b</sup></td><td>ZKR_S2 <sup>b</sup></td><td>ZKR_S3 <sup>b</sup></td><td>QXR <sup>c</sup>_S1</td><td>QXR_S2</td><td>QXR_S3</td></tr><tr><td>Raw reads</td><td>100,481,781</td><td>99,812,614</td><td>99,445,825</td><td>100,002,793</td><td>99,887,525</td><td>99,071,615<... |
6665a0f982c5ff2c085761ab7d163538d7cbcf6905b116335f67b2fb06e2359c.png | simple | <table><tr><td>Cross-linked polyurethane</td><td>Macrodiols</td><td>Diisocyanate</td><td>Chain extender</td><td>State at room temperature</td><td>T<sub>g</sub> (°C)</td><td><i>T</i><sub><i>m</i></sub> (°C)</td></tr><tr><td>CPU 1</td><td>PCEG 1</td><td>HDI</td><td>TMP</td><td>Hard</td><td>−45</td><td>46<... |
1e1bf45acf4127fec4c2715a7a3ab139b4533f2c18f001ba374498778fab92ed.png | simple | <table><tr><td>Striatal Region<sup>ψ</sup></td><td>PD (n = 65)</td><td>Healthy Controls (n = 27)</td><td>F(1,91)</td><td>p</td><td>Effect size</td></tr><tr><td>Normalized Caudate</td><td>0.416% (0.400 – 0.433)</td><td>0.468% (0.443 – 0.493)</td><td>11.38</td><td>0.001</td><td>−0.80</td></tr><tr><... |
6e035626f5a47ae6f104402e41d320be8429886195e981df220695af37107f1e.png | complex | <table><tr><td></td><td colspan="4">Aerobe genomes</td><td colspan="4">Anaerobe genomes</td><td colspan="4">Facultative genomes</td></tr><tr><td rowspan="3">Predictions</td><td>Aerobe</td><td>137</td><td>87</td><td>%</td><td>Aerobe</td><td>6</td><td>6</td><td>%</td><td>Aerobe</td><td>43</td><td>44</td><td>%</td></tr><t... |
cf56af6e2298c40519a3b8aad02e71641bb5cf99809cb5ccf344ae094f6c563e.png | complex | <table><tr><td colspan="3">Male to female ratio is 432(73%): 160(27%)</td></tr><tr><td>Characteristics</td><td>Cases (n = 296)</td><td>Controls (n = 296)</td></tr><tr><td></td><td>n* (%)</td><td>n* (%)</td></tr><tr><td>Marital status</td><td></td><td></td></tr><tr><td>- Married</td><td>227 (76.69%)</td><td>251 (84.80%)... |
f9b0ce1a3f23941778e9cc1a8bd85d0a0ffb7ec75c1ccd297044c0c4816d9515.png | simple | <table><tr><td>Annotation type</td><td>Content</td><td>Elements involved</td></tr><tr><td>Curatorial</td><td>Meta annotation referring annotations commented on by a curator. Each annotated value can be accepted, rejected and discussed</td><td>All elements of the curated annotation</td></tr><tr><td>Batch</td><td>Meta an... |
2b1a745200d190df21a1016c35a1d76eae98b44e46693ab4858b5681af51e1a6.png | simple | <table><tr><td>Outcome</td><td>Persons with symptomatic RHOA (<i>n</i> = 718), mean (s.d.)</td><td>Persons with EOA (<i>n</i> = 80), mean (s.d.)</td><td>Adjusted mean difference<sup>a</sup> (95% CI)</td></tr><tr><td>Female, <i>n</i> (%)</td><td>442 (62)</td><td>67 (84)</td><td>22.2 (13.4, 31.0)</td></tr><tr><td>Age, ye... |
7850b0b1fa83529112d7eabd9cd86f04d1b95a3a2a285d6157eeda65b48973f1.png | complex | <table><tr><td rowspan="2">Eikelboom morphotype<sup>a</sup></td><td rowspan="2">Taxonomy</td><td colspan="5">Classification</td></tr><tr><td>Phylum</td><td>Class</td><td>Order</td><td>Family</td><td>Genus</td></tr><tr><td rowspan="4">0092 (30)</td><td>RDP<sup>b</sup></td><td><i>Chloroflexi</i></td><td><i>Anaerolineae</... |
988f48ec6a8f2b5e942d940a233944d094ce872c4535b64cc80d855b20e8af21.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="3">Codes</td></tr><tr><td>−1</td><td>0</td><td>+1</td></tr><tr><td>Frying temperature (<sup>°</sup>C)</td><td>140</td><td>150</td><td>160</td></tr><tr><td>Frying time (min)</td><td>2</td><td>3</td><td>4</td></tr><tr><td>Level of BSCF (%)</td><td>20</td><t... |
f2f56fe2f4e1d83525dd921516d6e4c78845b885f3b1065923b9c4522a97de87.png | simple | <table><tr><td>Material</td><td>Element type</td><td>Constitutive relation</td><td>Material properties</td></tr><tr><td>Bony structures</td><td></td><td></td><td></td></tr><tr><td>Vertebral cortical bone, endplates, and posterior cortical bone</td><td>8 Nodes brick element (C3D8)</td><td>Isotropic, elastic</td><td><i>E... |
e1c384ef4948a16d4e6c1305ffb1b27556cf160551dd5dc8c81bcdd02873d841.png | complex | <table><tr><td></td><td colspan="6">Men</td><td colspan="8">Women</td></tr><tr><td></td><td colspan="2">Model 0</td><td colspan="2">Model 1</td><td colspan="2">Model 2</td><td colspan="2">Model 0</td><td colspan="2">Model 1</td><td colspan="2">Model 2</td><td colspan="2">Model 3b</td></tr><tr><td></td><td>OR</td><td></... |
cdf6bb3fba2f442abd2d00d2939009991eeb2a10ee73d5a624cac4bb302b723b.png | complex | <table><tr><td></td><td colspan="3">Frequency</td></tr><tr><td></td><td>Current employment</td><td>Not working as nurses</td><td>Total</td></tr><tr><td>1994</td><td>18</td><td>5</td><td>23</td></tr><tr><td>1995</td><td>13</td><td>5</td><td>18</td></tr><tr><td>1996</td><td>15</td><td>6</td><td>21</td></tr><tr><td>1997</... |
cc785b8e4b63f2da04ed6dd945fcb283d124876c6a3f46481f0838000a00306f.png | complex | <table><tr><td colspan="2"> </td><td>LFI strip test</td><td>DAS ELISA (OD)</td></tr><tr><td rowspan="3">Pig 77</td><td>Swap 1</td><td>+</td><td>1.717</td></tr><tr><td>Swap 2</td><td>+</td><td>1.3</td></tr><tr><td>Swap 3</td><td>+</td><td>0.307</td></tr><tr><td>Pig 78</td><td>Swap 1</td><td>+</td><td>0.604</td></tr><tr>... |
aa78872c4cd7038e9abbe4ca9c8794f460065d0b3e3c24f1225e9dfcb3a0dfe6.png | simple | <table><tr><td>Causes of pulmonary hypertension in ICU</td><td>Causes of RV failure in ICU</td></tr><tr><td>1) PAH (for example, preexisting PAH; PoPH (8.5% ESLD)</td><td>1) RV Pressure overload, pulmonary hypertension, any cause</td></tr><tr><td>2) Elevated LAP: RV pressure overload (left-sided myocardial infarction/c... |
252f68b4abf65d5b82890d0191c25cd3710fcfcb5a7232245751f5206413049a.png | complex | <table><tr><td>Gene</td><td>5′–3′ sequence</td></tr><tr><td rowspan="2"><i>P5CS1</i></td><td>F‐GTAGACGACGACGACGATAATG</td></tr><tr><td>R‐ACTGCTGTCCCAACCTTAAC</td></tr><tr><td rowspan="2"><i>P5CS2</i></td><td>F‐GGTGCTGAGGTGGGAATAAG</td></tr><tr><td>R‐ACTTGTCCCTTTCCTCTCATTATC</td... |
042e505ba6e8f03c5791843f32348c38822664c70bae401c94f3ede5f2473f9d.png | simple | <table><tr><td></td><td>First quartile</td><td>Third quartile</td></tr><tr><td>Shortwave radiation</td><td>164.97 (1.41)*</td><td>141.35(1.14)</td></tr><tr><td>HDD</td><td>134.62(1.22)</td><td>168.11(1.39)</td></tr><tr><td>Snowfall</td><td>135.04(1.24)</td><td>163.66(1.42)</td></tr><tr><td>Rainfall</td><td>164.69 (1.60... |
dfd2f0a62259c18dc1176048b31b767b26be7c4be92ee1bc7904cadc8fef3f99.png | simple | <table><tr><td>Author</td><td>Country</td><td>Year</td><td>Type of study</td><td>Patients</td><td>Control</td><td>Cut off (pmol/L)</td><td>TP</td><td>FP</td><td>FN</td><td>TN</td><td>SEN</td><td>SPE</td></tr><tr><td>Moore RG <i>et al</i>. [5]</td><td>USA</td><td>2008</td><td>prospective/retrospective</td><td>171</td><t... |
f17e733922aa880bbde08b831fbb173dc9da5b04e63cc94d11b485ea0a897bd9.png | simple | <table><tr><td>Training description</td><td>Related themes</td></tr><tr><td>1. Video: Invite for the workshop and foundational information on <i>Rx for Change</i> and systematic reviews<underline>Delivery:</underline> A video (prezi with audio narration) covering general information about <i>Rx for Change</i> and syste... |
ebafea3f86882c03d4a523702e9b74832a556fc0bab58ed0919c1a8691b6e81c.png | simple | <table><tr><td>Motif</td><td>Number of matches</td></tr><tr><td><i>P. pastoris</i> AT-ACS</td><td>15</td></tr><tr><td><i>P. pastoris</i> GC-ACS</td><td>1</td></tr><tr><td><i>S. cerevisiae</i> 11 bp ACS</td><td>11</td></tr><tr><td><i>S. cerevisiae</i> 17 bp ACS</td><td>6</td></tr></table> |
ab9282df63ff6f01700ce866b137e0b29fb790f81692eb9c7db23401b9fa5b5f.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">Overall</td><td colspan="2">AKI</td><td colspan="2">No AKI</td></tr><tr><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>N</td><td>14,651</td><td></td><td>1966</td><td>(13.4% of cohort)</td><td>12,685</td><td>(86.6% of cohort)</td></t... |
f9ab75b18ee973ac4094971069c6d3244dae3ea43401fac83009ce0ec13b234e.png | complex | <table><tr><td>Variables</td><td>Total cohort</td><td>Tsunami group</td><td>Radiation group</td><td>p value<sup>a</sup></td></tr><tr><td>Physical examination</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Body weight (kg)</td><td>58.5 (52.0–66.0)</td><td>57.9 (52.6–65.9)</td><td>59.5 (51.9–6... |
dc3be347dbe2e3686f145b59300266612222e681157682f51c67596b34c00e14.png | complex | <table><tr><td>Chromosomal arm</td><td>Total no. informative SNPs with LOH</td><td>No. informative SNPs with LOH and CN = 1 (fraction)</td><td>No. informative SNPs with LOH and CN = 2 (fraction)</td><td>No. informative SNPs with LOH and CN = 3 or 4 (fraction)</td></tr><tr><td>1p</td><td>10,576</td><td>2,930 (0.28)</td>... |
6a35034fd9bbab8693d4652b1c24b6602ea4a36e3440c927ae47068adaaf01f7.png | simple | <table><tr><td>Driers</td><td>Appearance</td><td>Odor</td><td>Taste</td><td>Flavor</td><td>Texture</td><td>Palability</td><td>Acceptability</td><td>Shelf-life (1–30 days)</td></tr><tr><td>Plastic</td><td>Attractive</td><td>Pleasant</td><td>Fair</td><td>Fair</td><td>Hard</td><td>Good</td><td>Moderate</td><td>Long<... |
d97c9fa4960ecf7d004a6cb7df773b91033af0a3b9e92542e463c5af5cd11820.png | simple | <table><tr><td>Condition</td><td>EGL</td><td>ESL</td><td>LSL</td><td>ESL (n.a.)</td><td>LSL (n.a.)</td></tr><tr><td>correct</td><td>94.7 (0.9)</td><td>92.0 (1.2)</td><td>82.5 (2.6)</td><td>92.0 (1.6)</td><td>82.1 (3.5)</td></tr><tr><td>semantics</td><td>97.6 (0.8)</td><td>94.2 (1.2)</td><td>94.5 (1.8)</td><td>93.1 (3.4... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.